Acknowledging the importance of immunophenotypic characterization in BPDCN, additional challenges arise when neoplastic cells do not meet the typical CD4 + /CD56 + /CD123 + /HLA-DR + /TCL1/CD303 + profile [8, 19]. Here, CD4 is linked to CD4+/CD56+ hematodermic neoplasm.